From: The methodology for developing a prospective meta-analysis in the family planning community
Institution | Primary investigator | Route & timing* of misoprostol administration | Site-specific primary outcome | Target recruitment |
---|---|---|---|---|
Emory University School of Medicine | Eva Lathrop | buccal 2 hours prior | Ability to have the IUD inserted without the use of ancillary measures including mechanical dilation of the cervix, placement of paracervical nerve block, or using abdominal ultrasound for guidance. | 75 |
Oregon Health & Science University | Alison Edelman | Buccal, 90 minutes | Patient perceived pain on 100-mm visual analogue scale (VAS;anchors:0 = none,100 mm = worst imaginable) | 40 |
University of Arizona | Pamela Lotke | Vaginal or buccal 2 hours prior | Patient perceived pain on 100-mm visual analogue scale (VAS;anchors:0 = none,100 mm = worst imaginable) | 60 |
University of Colorado | Stephanie Teal | Sublingual, 2 hours prior | Able to have the IUD inserted in a standard fashion without the ancillary measures of mechanical dilation of the cervix, placement of paracervical nerve block, or using abdominal ultrasound for guidance. | 150 |
University of New Mexico | Eve Espey | Buccal, 2 hours prior | Patient perceived pain on 100-mm visual analogue scale (VAS;anchors:0 = none,100 mm = worst imaginable) | 80 |
University of Utah | David Turok | Buccal or vaginal 2-4 hours prior | Operator perceived ease of insertion (based on a 100-mm visual analogue scale -anchors: 0 _ extremely easy, 100 mm_impossible). | 100 |